BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31209475)

  • 1. Evidence for enhanced Bruton's tyrosine kinase activity in transitional and naïve B cells of patients with granulomatosis with polyangiitis.
    von Borstel A; Abdulahad WH; Sanders JS; Rip J; Neys SFH; Hendriks RW; Stegeman CA; Heeringa P; Rutgers A; Corneth OBJ
    Rheumatology (Oxford); 2019 Dec; 58(12):2230-2239. PubMed ID: 31209475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 production.
    von Borstel A; Abdulahad WH; Dekkema G; Rutgers A; Stegeman CA; Veldman J; Heeringa P; Sanders JS
    PLoS One; 2020; 15(7):e0235743. PubMed ID: 32645052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro.
    Lepse N; Land J; Rutgers A; Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
    Rheumatology (Oxford); 2016 Jan; 55(1):162-72. PubMed ID: 26320128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory and effector B cell cytokine production in patients with relapsing granulomatosis with polyangiitis.
    Land J; Abdulahad WH; Sanders JS; Stegeman CA; Heeringa P; Rutgers A
    Arthritis Res Ther; 2016 Apr; 18():84. PubMed ID: 27044386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD27
    von Borstel A; Land J; Abdulahad WH; Rutgers A; Stegeman CA; Diepstra A; Heeringa P; Sanders JS
    Front Immunol; 2019; 10():2221. PubMed ID: 31608054
    [No Abstract]   [Full Text] [Related]  

  • 6. Skewing toward Treg and Th2 responses is a characteristic feature of sustained remission in ANCA-positive granulomatosis with polyangiitis.
    Szczeklik W; Jakieła B; Wawrzycka-Adamczyk K; Sanak M; Hubalewska-Mazgaj M; Padjas A; Surmiak M; Szczeklik K; Sznajd J; Musiał J
    Eur J Immunol; 2017 Apr; 47(4):724-733. PubMed ID: 28155222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Bruton's Tyrosine Kinase Activity in Peripheral Blood B Lymphocytes From Patients With Autoimmune Disease.
    Corneth OBJ; Verstappen GMP; Paulissen SMJ; de Bruijn MJW; Rip J; Lukkes M; van Hamburg JP; Lubberts E; Bootsma H; Kroese FGM; Hendriks RW
    Arthritis Rheumatol; 2017 Jun; 69(6):1313-1324. PubMed ID: 28141917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skewed peripheral B- and T-cell compartments in patients with ANCA-associated vasculitis.
    London J; Dumoitier N; Lofek S; Dion J; Chaigne B; Mocek J; Thieblemont N; Cohen P; Le Jeunne C; Guillevin L; Witko-Sarsat V; Varin-Blank N; Terrier B; Mouthon L;
    Rheumatology (Oxford); 2021 May; 60(5):2157-2168. PubMed ID: 33026090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bruton's tyrosine kinase is a possible therapeutic target in microscopic polyangiitis.
    Nakade I; Tamura Y; Hashimoto F; Ariza Y; Hotta S; Fujigaya H; Arai S; Taniguchi M; Ogawa H; Nishibata Y; Masuda S; Nakazawa D; Tomaru U; Ishizu A
    Arthritis Res Ther; 2023 Nov; 25(1):215. PubMed ID: 37932784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of IL-21 signalling pathway through Bruton's tyrosine kinase in human B cell activation.
    Wang SP; Iwata S; Nakayamada S; Niiro H; Jabbarzadeh-Tabrizi S; Kondo M; Kubo S; Yoshikawa M; Tanaka Y
    Rheumatology (Oxford); 2015 Aug; 54(8):1488-97. PubMed ID: 25724205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis.
    Granel J; Lemoine R; Morello E; Gallais Y; Mariot J; Drapeau M; Musnier A; Poupon A; Pugnière M; Seren S; Nouar D; Gouilleux-Gruart V; Watier H; Korkmaz B; Hoarau C
    Front Immunol; 2020; 11():573040. PubMed ID: 33101296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kv1.3 Channel Blockade Modulates the Effector Function of B Cells in Granulomatosis with Polyangiitis.
    Land J; Lintermans LL; Stegeman CA; Muñoz-Elías EJ; Tarcha EJ; Iadonato SP; Heeringa P; Rutgers A; Abdulahad WH
    Front Immunol; 2017; 8():1205. PubMed ID: 29018452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ detection of PR3-ANCA
    Weppner G; Ohlei O; Hammers CM; Holl-Ulrich K; Voswinkel J; Bischof J; Hasselbacher K; Riemekasten G; Lamprecht P; Ibrahim S; Iking-Konert C; Recke A; Müller A
    J Autoimmun; 2018 Sep; 93():89-103. PubMed ID: 30054207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune stimulatory effects of neutrophil extracellular traps in granulomatosis with polyangiitis.
    Lange C; Csernok E; Moosig F; Holle JU
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):33-39. PubMed ID: 28281454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56(dim) natural killer cells.
    Merkt W; Claus M; Blank N; Hundemer M; Cerwenka A; Lorenz HM; Watzl C
    Arthritis Res Ther; 2016 Sep; 18(1):204. PubMed ID: 27624647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kv1.3 blockade by ShK186 modulates CD4+ effector memory T-cell activity of patients with granulomatosis with polyangiitis.
    Lintermans LL; Stegeman CA; Muñoz-Elías EJ; Tarcha EJ; Iadonato SP; Rutgers A; Heeringa P; Abdulahad WH
    Rheumatology (Oxford); 2024 Jan; 63(1):198-208. PubMed ID: 37086441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis (GPA).
    Abdulahad WH; Lepse N; Stegeman CA; Huitema MG; Doornbos-van der Meer B; Tadema H; Rutgers A; Limburg PC; Kallenberg CG; Heeringa P
    Arthritis Res Ther; 2013; 15(3):R70. PubMed ID: 23799890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating T follicular helper cell and regulatory T cell frequencies are influenced by B cell depletion in patients with granulomatosis with polyangiitis.
    Zhao Y; Lutalo PM; Thomas JE; Sangle S; Choong LM; Tyler JR; Tree T; Spencer J; D'Cruz DP
    Rheumatology (Oxford); 2014 Apr; 53(4):621-30. PubMed ID: 24357812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood natural killer cell percentages in granulomatosis with polyangiitis correlate with disease inactivity and stage.
    Merkt W; Sturm P; Lasitschka F; Tretter T; Watzl C; Saure D; Hundemer M; Schwenger V; Blank N; Lorenz HM; Cerwenka A
    Arthritis Res Ther; 2015 Nov; 17():337. PubMed ID: 26589807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulomatosis with polyangiitis involves sustained mucosal inflammation that is rich in B-cell survival factors and autoantigen.
    Zhao Y; Odell E; Choong LM; Barone F; Fields P; Wilkins B; Tungekar FM; Patel P; Sanderson JD; Sangle S; D'Cruz D; Spencer J
    Rheumatology (Oxford); 2012 Sep; 51(9):1580-6. PubMed ID: 22627727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.